Ghigo, A., Ameri, P., Asnani, A., Bertero, E., de Boer, R. A., Farmakis, D., González, A., Heymans, S., Ibáñez, B., López-Fernández, T., Lyon, A. R., Pollesello, P., Rakisheva, A., Stellos, K., Streckfuss-Bömeke, K., Tocchetti, C. G., Thum, T., van der Meer, P., Van Rooij, E., ... Van Linthout, S. (2025). Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. European journal of heart failure, 27(6), 1028-1046. https://doi.org/10.1002/ejhf.3636

Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143

Michel, L. Y. M., Esfahani, H., De Mulder, D., Verdoy, R., Ambroise, J., Roelants, V., Bouchard, B., Fabian, N., Savary, J., Dewulf, J. P., Doumont, T., Bouzin, C., Haufroid, V., Luiken, J. J. F. P., Nabben, M., Singleton, M. L., Bertrand, L., Ruiz, M., Des Rosiers, C., & Balligand, J.-L. (2025). An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress. Circulation, 151(18), 1312-1328. https://doi.org/10.1161/CIRCULATIONAHA.124.067876

Groeneweg, J. A., van Dalen, B. M., Cox, M. P. G. J., Heymans, S., Braam, R. L., Michels, M., & Asselbergs, F. W. (2025). 2023 European Society of Cardiology guidelines on the management of cardiomyopathies: Statement of endorsement by the NVVC. Netherlands Heart Journal, 33(5), 148-156. https://doi.org/10.1007/s12471-025-01955-2

Gingele, A. J., & Rocca, H.-P. B.-L. (2025). Enhancing heart failure detection and patient engagement with the Maastricht Decompensation Questionnaire. Netherlands Heart Journal, 33(5), 181. https://doi.org/10.1007/s12471-025-01945-4

Pinckaers, N. E. T., Blankesteijn, W. M., Mircheva, A., Punt, A., Opperhuizen, A., van Schooten, F.-J., & Vrolijk, M. (2025). Quantitative in vitro-to-in vivo extrapolation of human adrenergic and trace amine-associated receptor 1 potencies of pre-workout supplement ingredients using physiologically based kinetic modelling-based reverse dosimetry. Archives of Toxicology, 99(5), 1999-2021. https://doi.org/10.1007/s00204-025-03992-7

Karakasis, P., Lefkou, E., Pamporis, K., Heymans, S., Filippatos, G., & Fragakis, N. (2025). Reply to the letter regarding the article 'Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis'. European journal of heart failure, 27(5), 933-934. https://doi.org/10.1002/ejhf.3660

Mourmans, S. G. J., Achten, A., Hermans, R., Scheepers, M. J. E., D'Alessandro, E., Swennen, G., Woudstra, J., Appelman, Y., Goor, H. V., Schalkwijk, C., Knackstedt, C., Weerts, J., Eringa, E. C., & van Empel, V. P. M. (2025). The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 182. https://doi.org/10.1186/s12933-025-02679-8

Gigli, M., Stolfo, D., Barbati, G., Graw, S., Chen, S. N., Merlo, M., Medo, K., Gregorio, C., Dal Ferro, M., Paldino, A., Perotto, M., Peter van Tintelen, J., Te Riele, A. S. J. M., Baas, A. F., Wilde, A. M., Amin, A. S., Houweling, A. C., Elliott, P., Cannie, D., ... Filamin C Registry Consortium (2025). Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants. JAMA Cardiology, 10(4), 359-369. https://doi.org/10.1001/jamacardio.2024.5543

Vranken, N. P. A., Li, X., Bouman, H., Mourmans, S. G. J., Achten, A., Aizpurua, A. B., Brunner-La Rocca, H.-P., Knackstedt, C., van Empel, V. P. M., & Weerts, J. (2025). Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 156. https://doi.org/10.1186/s12933-025-02708-6

Achten, A., Weerts, J., van Koll, J., Ghossein, M., Mourmans, S. G. J., Aizpurua, A. B., van Stipdonk, A. M. W., Vernooy, K., Prinzen, F. W., Rocca, H.-P. B.-L., Knackstedt, C., & van Empel, V. P. M. (2025). Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction. IJC Heart and Vasculature, 57, Article 101622. https://doi.org/10.1016/j.ijcha.2025.101622

Huang, Y., Chen, H., Chen, W., Chen, W., Zhong, Q., Pei, J., Zhang, M., & Haenen, G. R. M. M. (2025). Development and Application of Polyphenols in Food: A Comprehensive Review. Food Frontiers, 6(3), 1287-1302. https://doi.org/10.1002/fft2.533

Karakasis, P., Lefkou, E., Pamporis, K., Farmakis, D., Patoulias, D., Antoniadis, A. P., Heymans, S., Filippatos, G., & Fragakis, N. (2025). Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. European journal of heart failure. Advance online publication. https://doi.org/10.1002/ejhf.3637

Monzo, L., Kobayashi, M., Ferreira, J. P., Lamiral, Z., Delles, C., Clark, A. L., Edelmann, F., González, A., Heymans, S., Pellicori, P., Petutschnigg, J., Verdonschot, J. A. J., Rossignol, P., Cleland, J. G. F., Zannad, F., Girerd, N., & HOMAGE “Heart Omics in AGEing” Trial Committees and Investigators (2025). Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial. Cardiovascular Diabetology, 24(1), Article 111. https://doi.org/10.1186/s12933-025-02609-8

Mestrum, S. G. C., Schoenmakers, T., Wang, S. J., de Wit, N. C. J., Boonen, B. T., van Hemert, W. L. W., Deneer, R., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2025). Increased anti-apoptotic (Bcl-2+) and decreased proliferative (Ki-67+) cell fractions during the different maturation stages of bone marrow cell populations in MDS and AML: The potential diagnostic impact of the Bcl-2. Cytometry. Part B, Clinical cytometry, 108(2), 146-160. https://doi.org/10.1002/cyto.b.22231

Timmer, L. T., den Hertog, E., Versteeg, D., Post, H., Verdonschot, J. A. J., Monshouwer-Kloots, J., Kyriakopoulou, E., Perini, I., Koopmans, T., van der Kraak, P., Zentilin, L., Heymans, S. R. B., Vink, A., Giacca, M., Heck, A. J. R., & van Rooij, E. (2025). Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix composition. Cardiovascular Research, 121(4), 585-600. Article cvaf021. https://doi.org/10.1093/cvr/cvaf021

Gingele, A. J., Amin, H., De Wit, K., Jacobsen, M., Hageman, A., van der Mierden, K., Brandts, J., Weerts, J., Barrett, M., Dixon, L. J., Hill, L., Knackstedt, C., & Brunner-La Rocca, H.-P. (2025). Developing an artificial intelligence-based decision engine for disease-modifying therapy in heart failure: a pilot study. European Heart Journal - Digital Health, 6(2), 285-288. https://doi.org/10.1093/ehjdh/ztad075

Schoonvelde, S. A. C., Wiethoff, I., Zwetsloot, P. P., Hirsch, A., Knackstedt, C., Germans, T., Sikking, M., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., Evers, S. M. A. A., Hiligsmann, M., & Michels, M. (2025). Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study. European heart journal - Quality of care & clinical outcomes, 11(2), 174-185. https://doi.org/10.1093/ehjqcco/qcae092

Vangrieken, P., Scheijen, J. L. J. M., Schiffers, P. M. H., van de Waarenburg, M. P. H., Foulquier, S., & Schalkwijk, C. C. G. (2025). Modelling the effects of elevated methylglyoxal levels on vascular and metabolic complications. Scientific Reports, 15(1), Article 6025. https://doi.org/10.1038/s41598-025-90661-5

Donker, E. M., van Rosse, F., Janssen, B. J. A., Knol, W., Dumont, G., van Smeden, J., Atiqi, R., Hessel, M., Richir, M. C., van Agtmael, M. A., Kramers, C., Tichelaar, J., & Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy (2025). Students' perspective on the Dutch National Pharmacotherapy Assessment, a national survey study among final-year medical students. European Journal of Pharmacology, 989, Article 177266. https://doi.org/10.1016/j.ejphar.2025.177266

Donker, E. M., van Rosse, F., Janssen, B. J. A., Knol, W., Dumont, G., van Smeden, J., Atiqi, R., Hessel, M., Richir, M. C., van Agtmael, M. A., Kramers, C., Tichelaar, J., & Education committee of the Dutch Society for Clinical Pharmacology and Biopharmacy (2025). The impact of summative, formative or programmatic assessment on the Dutch National Pharmacotherapy Assessment: a retrospective multicentre study. European Journal of Pharmacology, 989, Article 177267. https://doi.org/10.1016/j.ejphar.2025.177267

Achten, A., Muller, S. A., Zwetsloot, P.-P., Michels, M., van der Meer, P., Nienhuis, H. L. A., van der Meer, M. G., van Empel, V. P. M., Oerlemans, M. I. F. J., & Knackstedt, C. (2025). Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?Expert review of cardiovascular therapy, 23(1-2), 1-4. https://doi.org/10.1080/14779072.2025.2463333

Grootaert, M. O. J., Pasut, A., Raman, J., Simmonds, S. J., Callewaert, B., Col, Ü., Dewerchin, M., Carmeliet, P., Heymans, S., & Jones, E. A. V. (2025). Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodelling. Cardiovascular Diabetology, 24(1), Article 62. https://doi.org/10.1186/s12933-025-02623-w

Stroeks, S. L. V. M., Muller, S., Beelen, N. J., Venner, M. F. G. H. M., Baas, A. F., van Empel, V. P. M., Krapels, I. P. C., Hazebroek, M. R., Te Riele, A. S. J. M., & Verdonschot, J. A. J. (2025). Family Screening in Patients With Dilated and Arrhythmogenic Cardiomyopathy: The Road Toward Gene-Specific Recommendations. Circulation: Genomic and Precision Medicine, 18(1), Article e004778. https://doi.org/10.1161/CIRCGEN.124.004778

Mourmans, S. G. J., Weerts, J., Baumert, M., Aizpurua, A. B., Achten, A., Knackstedt, C., Linz, D., & van Empel, V. P. M. (2025). Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction. Esc heart failure, 12(1), 622-630. https://doi.org/10.1002/ehf2.15116

Li, C., Wang, Y., Liang, J., Haenen, G. R. M. M., Chen, Y., Li, Z., Zhang, M., & Dubois, L. J. (2025). Exploring the Anticancer Potential of MonoHER (7-Mono-O-(β-Hydroxyethyl)-Rutoside): Mitochondrial-Dependent Apoptosis in HepG2 Cells. Current Issues in Molecular Biology, 47(1), Article 36. https://doi.org/10.3390/cimb47010036

Baker, M. B., Hazell, G., van Rijt, S., Blankesteijn, W. M., Welting, T., den Akker, G. V., & Bauer, J. (2025). Teaching Chemistry in the New Bachelor “Regenerative Medicine and Technology”. Croatica Chemica Acta, 98(2), 157-166. https://doi.org/10.5562/cca4185

Manukjan, N., Fulton, D., Ahmed, Z., Blankesteijn, W. M., & Foulquier, S. (2025). Vascular endothelial growth factor: a double-edged sword in the development of white matter lesions. Neural Regeneration Research, 20(1), 191-192. https://doi.org/10.4103/NRR.NRR-D-23-01843

Gingele, A. J., Beckers, F., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Fluid status assessment in heart failure patients: pilot validation of the Maastricht Decompensation Questionnaire. Netherlands Heart Journal, 33(1), 7-13. https://doi.org/10.1007/s12471-024-01921-4

Stroeks, S. L. V. M., Henkens, M. T. H. M., Dominguez, F., Merlo, M., Hellebrekers, D. M. E. I., Gonzalez-Lopez, E., Dal Ferro, M., Ochoa, J. P., Venturelli, F., Claes, G. R. F., Venner, M. F. G. H. M., Krapels, I. P. C., Vanhoutte, E. K., van Paassen, P., van den Wijngaard, A., Sikking, M. A., van Leeuwen, R., Abdul Hamid, M., Li, X., ... Verdonschot, J. A. J. (2025). Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease. JACC: Heart Failure, 13(1), 133-145. https://doi.org/10.1016/j.jchf.2024.08.011

Van Linthout, S., Stellos, K., Giacca, M., Bertero, E., Cannata, A., Carrier, L., Garcia-Pavia, P., Ghigo, A., Gonzalez, A., Haugaa, K. H., Imazio, M., Lopes, L. R., Most, P., Pollesello, P., Schunkert, H., Streckfuss-Boemeke, K., Thum, T., Tocchetti, C. G., Tschoepe, C., ... Heymans, S. (2025). State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases. European journal of heart failure, 27(1), 5-25. https://doi.org/10.1002/ejhf.3516

de Jong, M. B. L., Allach, Y., Kamar, S. A., Clephas, P. R. D., Brunner-La Rocca, H. P., Handoko, M. L., van de Halm, V. P., Kok, W. E. M., Asselbergs, F. W., van Kimmenade, R., Beeres, S. L. M. A., Rienstra, M., Szymanski, M. K., de Boer, R. A., Kardys, I., & Brugts, J. J. (2025). The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring. Journal of Cardiac Failure. Advance online publication. https://doi.org/10.1016/j.cardfail.2025.04.014

Salavati, A., van der Wilt, C. N., Calore, M., van Es, R., Rampazzo, A., van der Harst, P., van Steenbeek, F. G., van Tintelen, J. P., Harakalova, M., & Te Riele, A. S. J. M. (2024). Artificial Intelligence Advancements in Cardiomyopathies: Implications for Diagnosis and Management of Arrhythmogenic Cardiomyopathy. Current Heart Failure Reports, 22(1), Article 5. https://doi.org/10.1007/s11897-024-00688-4

Sikking, M. A., Harding, D., Henkens, M. T. H. M., Stroeks, S. L. V. M., Venner, M. F. G. H. M., Nihant, B., van Leeuwen, R. E. W., Fanti, S., Li, X., van Paassen, P., Knackstedt, C., Brunner-la Rocca, H.-P., van Empel, V. P. M., Verdonschot, J. A. J., Marelli-Berg, F. M., & Heymans, S. R. B. (2024). Cytotoxic T-Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy. Circulation Research, 135(12), 1193-1195. https://doi.org/10.1161/CIRCRESAHA.124.325183

Vencato, S., Cagnin, S., Romanato, C., Murali, K., Ferron, S., Becchi, T., Velle, A., Sales, G., Romualdi, C., Rakszewska, A., Conrad, C., Braghetta, P., Vitiello, L., Rampazzo, A., & Calore, M. (2024). Characterization of a novel transgenic mouse model for arrhythmogenic cardiomyopathy: phenotype and heart transcriptome profile. European Journal of Human Genetics, 32, 1386-1386.

Achten, A., Muller, S. A., Wijk, S. S., van der Meer, M. G., van der Harst, P., van Tintelen, P., Te Riele, A. S., van Empel, V., Oerlemans, M. I., & Knackstedt, C. (2024). Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction. Annals of Medicine, 56(1), Article 2418965. https://doi.org/10.1080/07853890.2024.2418965

Léger, L., Aalders, J., Heymans, N., Van Acker-Verberckt, K., De Bleeckere, L., Coucke, P., Menten, B., Bauce, B., Vitiello, L., Rampazzo, A., Calore, M., & van Hengel, J. (2024). Generation of a human induced pluripotent stem cell line UGENTi002-A from an arrhythmogenic cardiomyopathy patient carrying the c.817C>T DSP heterozygous variant and isogenic control using CRISPR/Cas9 editing. Stem Cell Research, 81, Article 103537. https://doi.org/10.1016/j.scr.2024.103537

Verdonschot, J. A. J., Fuster, J. J., Walsh, K., & Heymans, S. R. B. (2024). The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy. European Heart Journal, 45(45), 4797-4807. Article ehae682. https://doi.org/10.1093/eurheartj/ehae682

Hoen, M., Hofman, D. E., Hompes, B. H. A., Peeters, L. E. E., Langenveld, B., van Kimmenade, R. R. J., Frenken, L. A. M., Lenderink, T., Brunner-La Rocca, H. P., & Sanders-Van Wijk, S. (2024). The role of urine sodium in acutely decompensated heart failure. IJC Heart and Vasculature, 55, Article 101509. https://doi.org/10.1016/j.ijcha.2024.101509

Wei, F.-F., Mariottoni, B., An, D.-W., Pellicori, P., Yu, Y.-L., Verdonschot, J. A. J., Liu, C., Ahmed, F. Z., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J., Girerd, N., Li, Y., Clark, A. L., Nawrot, T. S., Ferreira, J. P., Zannad, F., Cleland, J. G. F., ... HOMAGE investigators (2024). Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure. Esc heart failure, 11(6), 4116-4126. https://doi.org/10.1002/ehf2.15000

Wei, F.-F., Pellicori, P., Ferreira, J. P., González, A., Mariottoni, B., An, D.-W., Verdonschot, J. A. J., Liu, C., Ahmed, F. Z., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J., Girerd, N., Clark, A. L., Li, Y., Nawrot, T. S., Díez, J., Zannad, F., ... HOMAGE investigators (2024). Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial. Hypertension Research, 47(11), 3225-3236. https://doi.org/10.1038/s41440-024-01843-z

Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Beckers-Wesche, F., Spanjers, M., Gingele, A., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2024). Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six years. Heart and Vessels, 39(10), 857-866. https://doi.org/10.1007/s00380-024-02408-3

Piët, J. D., Booth, A., Donker, E. M., de Ponti, F., Lunghi, C., Poluzzi, E., Janssen, B. J. A., Tun, S., Bekker, C., Dima, L., Costa, J., Jalving, M., Oude Munnink, T. H., van den Bemt, P. M. L. A., Labriffe, M., van Emden, T., van Waardenburg, V., Likic, R., Richir, M., ... Tichelaar, J. (2024). Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation. The Lancet. Planetary health, 8(10), e715-e716. https://doi.org/10.1016/S2542-5196(24)00230-4

Patwala, A., Barker, D., Da Costa, A., Bayard, G., Brunner-La Rocca, H. P., Fontes-Carvalho, R., De la Fuente, L., Goralski, M., Mahon, N. G., Roque, D., Santos, M., Yousef, Z., Ben Hamouda, H., Teal, M., Christory, F., Ahmed, F. Z., & Mebazaa, A. (2024). Optimizing heart failure pathways to enhance patient care: the Program to Optimize Heart Failure Patient Pathways (PRO-HF). Esc heart failure, 11(5), 2578-2590. https://doi.org/10.1002/ehf2.14911

Verdonschot, J. A. J., Heymans, S. R. B., & Van Linthout, S. (2024). The next era of gene-specific clinical care in patients with dilated cardiomyopathy. European journal of heart failure, 26(10), 2169-2172. https://doi.org/10.1002/ejhf.3446

Li, Z., Xu, L., Huang, D., Li, C., Haenen, G. R. M. M., & Zhang, M. (2024). NR0B2 Is a Key Factor for Gastric Diseases: A GEO Database Analysis Combined with Drug-Target Mendelian Randomization. Genes, 15(9), Article 1210. https://doi.org/10.3390/genes15091210

Yu, Y.-L., Siwy, J., An, D.-W., González, A., Hansen, T., Latosinska, A., Pellicori, P., Ravassa, S., Mariottoni, B., Verdonschot, J. A., Ahmed, F., Petutschnigg, J., Rossignol, P., Heymans, S., Cuthbert, J. J., Girerd, N., Clark, A. L., Verhamme, P., Nawrot, T. S., ... HOMAGE investigators (2024). Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart, 110(19), 1180-1187. Article heartjnl-2023-323796. https://doi.org/10.1136/heartjnl-2023-323796

Vilaça, A., Jesus, C., Lino, M., Hayman, D., Emanueli, C., Terracciano, C. M., Fernandes, H., de Windt, L. J., & Ferreira, L. (2024). Extracellular vesicle transfer of lncRNA H19 splice variants to cardiac cells. Molecular Therapy - Nucleic Acids, 35(3), Article 102233. https://doi.org/10.1016/j.omtn.2024.102233

Caiani, E. G., Kemps, H., Hoogendoorn, P., Asteggiano, R., Bohm, A., Borregaard, B., Boriani, G., Brunner La Rocca, H.-P., Casado-Arroyo, R., Castelletti, S., Christodorescu, R. M., Cowie, M. R., Dendale, P., Dunn, F., Fraser, A. G., Lane, D. A., Locati, E. T., Malaczynska-Rajpold, K., Mersa, C. O., ... Szymanski, P. (2024). Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee. European Heart Journal - Digital Health, 5(5), 509-523. https://doi.org/10.1093/ehjdh/ztae042

Muller, S. A., Peiro-Aventin, B., Biagioni, G., Tini, G., Saturi, G., Kronberger, C., Achten, A., Dobner, S., te Rijdt, W. P., Gasperetti, A., te Riele, A. S. J. M., Varra, G. G., Ponziani, A., Hirsch, A., Porcari, A., van Der Meer, M. G., Zampieri, M., van Der Harst, P., Kammerlander, A., ... Oerlemans, M. I. F. J. (2024). Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis. European journal of heart failure, 26(9), 2025-2034. https://doi.org/10.1002/ejhf.3339